RoboticsAI

Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System

Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System

16 days ago   |   Xconomy

It may seem like an unlikely link but the body's response to arthritis may hold answers for better cancer drugs, says Luis Voloch, chief technology officer of startup Immunai...
Read more ...

Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies

Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies

18 days ago   |   Xconomy

Pliant Therapeutics has a pipeline of experimental fibrosis treatments and a research alliance with Novartis. Now the biotech is preparing an IPO to raise cash to advance its...
Read more ...

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

1 month ago   |   Xconomy

A growing number of drug developers are embracing artificial intelligence as a tool for finding new medicines. Lantern Pharma is betting the technology can also resurrect...
Read more ...

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera's Cash & More

Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera's Cash & More

2 monthes ago   |   Xconomy

The financial markets are tumbling , event cancellations are mounting , and sports leagues are suspending their seasons. March Madness is in full swing but not in any way that...
Read more ...

Titan Medical's Cash Crunch Stalls Plans to Get Surgical Robot to FDA

Titan Medical's Cash Crunch Stalls Plans to Get Surgical Robot to FDA

3 monthes ago   |   Xconomy

Titan Medical didn't meet its goal of submitting its robotic surgical system for FDA clearance by the end of 2019. Now the company says it needs another $85 million to get its...
Read more ...

Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More

Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More

6 monthes ago   |   Xconomy

Lung injuries connected to the use of electronic cigarettes have topped 2,000 and killed 40 people, according to the Centers for Disease Control and Prevention. It's still...
Read more ...

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR'd Kidneys & More

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR'd Kidneys & More

6 monthes ago   |   Xconomy

During the state of the union address this year, President Trump pledged to end HIV transmission within the next decade. A key part of that plan is an HIV prevention drug made...
Read more ...

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

6 monthes ago   |   Xconomy

When Mark Bakken formed the healthcare technology investment firm HealthX Ventures nearly five years ago , he says hospitals, insurers, and other potential buyers of digital...
Read more ...

AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund

6 monthes ago   |   Xconomy

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to...
Read more ...

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

7 monthes ago   |   Xconomy

New brand-name drugs typically grab the life science headlines. A venture capital firm will invest tens of millions to develop one and a pharmaceutical company hopes to recoup...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...

High-yield production of l-serine through a novel identified exporter...

L-Serine has wide and increasing applications in industries with fast-growing market demand. Although strategies for achieving and improving l-serine production in... Read more ...